SABCS Roundup: BeiGene and Pfizer CDK4 inhibitors, ALX’s CD47

This year’s San Antonio Breast Cancer Conference yielded major clinical updates on some of the hottest areas of oncology, from VEGF bispecifics that hope to challenge Merck’s Keytruda on efficacy to ...